EN
HI
Summary
As of 10 Sep, 2026, Advanced Enzyme Technologies stock price is ₹299.5. During the trading session, the stock has moved between an intraday low of ₹296.00 and an intraday high of ₹302.90. Over the last 52 weeks, Advanced Enzyme Technologies has traded between ₹251.95 and ₹419.00.
The stock has recorded a trading volume of 1,59,172 shares,. Its Average Traded Price (ATP) is ₹299.98, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹299.50.
Advanced Enzyme Technologies has an upper circuit limit of ₹358.60 and a lower circuit limit of ₹239.10. The total value traded stands at ₹4.77 CR, and the delivery percentage for the day is 53.97%.
The stock is currently traded with a market lot size of 1. Advanced Enzyme Technologies also offers a dividend yield of 1.79%.
Advanced Enzyme Technologies Share Price Chart
Advanced Enzyme Technologies Share Key Metrics
Volume
1.59 L
Market Cap
3353.69 CR
LTQ@LTP
2@299.50
ATP
299.98
Var Margin
19.11 %
Circuit Range
239.1-358.6
Delivery %
53.97 %
Value
4.77 CR
ASM/GSM
No
Market Lot
1
Advanced Enzyme Technologies Fundamentals
P/E Ratio
20.22
P/B Ratio
2.02
Div. Yield
1.79
Sector P/E
41.95
Sector P/B
3.63
Sec. Div. Yield
0.5
Advanced Enzyme Technologies Resistance and Support
Pivot 298.97
Resistance
First Resistance
301.64
Second Resistance
304.42
Third Resistance
307.09
Support
First Support
296.19
Second Support
293.52
Third Support
290.74
Advanced Enzyme Technologies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Sep 09 2026 | 298.45 | 299.5 | 0.22% | 302.9 | 296 |
| Tue Sep 08 2026 | 297.75 | 298.85 | 0.34% | 301.75 | 296.29 |
| Mon Sep 07 2026 | 293.2 | 297.85 | 1.59% | 298.5 | 292.2 |
Advanced Enzyme Technologies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-08 | Quarterly Results & Buy Back |
| 2026-05-09 | Audited Results & Dividend |
| 2026-01-31 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-02 | Quarterly Results |
| 2025-05-13 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Advanced Enzyme Technologies News
Advanced Enzyme Technologies Ltd - 540025 - Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended)
Advanced Enzyme Tech has received requests from five promoter group members to reclassify them from the 'Promoter Group' to the 'Public' category. These members currently hold no shares and state no control or involvement in the company's management. The reclassification is sought under SEBI LODR Regulation 31A and is subject to Board approval.
Sep 05 2026 11:29:13
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Advanced Enzyme Technologies has made the audio recording of its conference call for the unaudited financial results for the quarter ended June 30, 2026, available on the company website. Investors can access the discussion on the company's Q1 FY27 performance.
Aug 12 2026 21:09:22
Read More
Advanced Enzyme Technologies Management
| Name | Position |
|---|---|
| Sanjay Basantani | Company Secretary & Compliance Officer, Head-Legal |
| Vasant Rathi | Chairman |
Advanced Enzyme Technologies Similar Stocks
SMS Pharmaceuticals Ltd.
407.30
8.15 (2.04%)
Indraprastha Medical Corporation Ltd.
360.20
5.05 (1.42%)
Kwality Pharmaceuticals Ltd.
3577.00
-84.40 (2.31%)
Solara Active Pharma Sciences Ltd.
690.50
-11.30 (1.61%)
Ind-Swift Laboratories Ltd.
388.55
0.25 (0.06%)
Hikal Ltd.
240.69
-5.32 (2.16%)
Dishman Carbogen Amcis Ltd.
170.59
-3.39 (1.95%)
Sakar Healthcare Ltd.
1152.35
-5.50 (0.48%)
Dr Agarwals Eye Hospital Ltd.
5241.50
-26.00 (0.49%)
Advanced Enzyme Technologies FAQs
The Buying Price of Advanced Enzyme Technologies share is 299.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Advanced Enzyme Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Advanced Enzyme Technologies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Advanced Enzyme Technologies shares is 20.22. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Advanced Enzyme Technologies shares is 2.02. Useful to assess the stock's value relative to its book value.
To assess Advanced Enzyme Technologies’s valuation compare Sector P/E, P/B which are 41.95 & 3.63 with sector averages, along with growth rates and financial metrics.
The Market Cap of Advanced Enzyme Technologies is 3353.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Advanced Enzyme Technologies share price is 419.00 & 251.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Advanced Enzyme Technologies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ADVENZYMES
Or Download Choice FinX App
Invest in ADVENZYMES
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade